Traws Pharma TRAW
NASDAQ TRAW
$0.38 0.00 (-0.45%)
As of: Oct 21, 2026 · 12:40 PM EDT

Traws Pharma (TRAW) Other financing activities (2025)

Updated

Traws Pharma's Other financing activities came in at $500,000 for FY2014, unchanged from $500,000 in FY2013.

Analysis

Traws Pharma (TRAW) Other financing activities (2025) Analysis & Trends

  • Other financing activities carries a three-year compound annual growth rate of -14.2% (FY2011 to FY2014).
  • Per Business Quant, earlier years put Other financing activities at $500,000 in FY2013 and $792,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn
10 Traws Pharma 5.95 Mn -12.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.94 Mn
Sep 30, 2025 -178,000.00
Jun 30, 2025 -164,000.00
Mar 31, 2025 -123,000.00
API Access

Traws Pharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TRAW&period=max&api_key=YOUR_API_KEY